Dr. Samuel Zhang, Chief Business Officer of Innovent, stated: "We are delighted to once again enter a strategic collaboration with Roche, a global leader in oncology, to advance our potentially ...
Innovent Biologics, a biopharmaceutical company based in Shuzou, China, has agreed a collaboration with Roche to develop ...
During the conference, Dr. De-Chao Michael Yu, Founder, Chairman and CEO of Innovent, delivered a presentation highlighting 2025 as a pivotal year for significantly business growth and concreate steps ...
Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, Adimab, LG Chem and MD Anderson Cancer Center. Guided by the motto, "Start with Integrity ...
INNOVENT BIO (01801.HK) has issued a statement to clarify the unusual price and trading volume movements of its shares. It ...
Hosted on MSN23d
Innovent and Roche link on lung cancer therapy developmentInnovent Biologics chief business officer Dr Samuel Zhang stated: “By combining Roche's scientific expertise and global development capabilities with our innovative approach, we are taking a ...
will receive exclusive global rights to develop, manufacture, and commercialize IBI3009 in exchange for $80M in upfront payment and up to $1B in milestone-based payments for Innovent (OTCPK ...
Innovent partners with over 30 global healthcare companies, including Eli Lilly, Sanofi, Incyte, Adimab, LG Chem and MD Anderson Cancer Center. Guided by the motto, "Start with Integrity ...
Dr. Samuel Zhang, Chief Business Officer of Innovent, stated: "We are delighted to once again enter a strategic collaboration with Roche, a global leader in oncology, to advance our potentially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results